Q3 2014 Holdings
Filed 2014-10-23 | 6 holdings | $129.6K | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2015-05-14) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| T2 Biosystems, Inc.A | Common Stock | 89853L104 | $43.0K | 2,374,571 | 33.2% |
| Trevena, Inc. | Common Stock | 89532E109 | $24.2K | 3,769,280 | 18.7% |
| Genocea Biosciences, Inc. | Common Stock | 372427104 | $18.6K | 2,055,230 | 14.4% |
| Bind Therapeutics, Inc. | Common Stock | 05548N107 | $17.3K | 2,018,253 | 13.4% |
| Cerulean Pharma Inc | Common Stock | 15708Q105 | $13.9K | 3,287,529 | 10.7% |
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $12.6K | 2,473,186 | 9.7% |